Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


04.09.2017

1 BMC Cancer
1 Cancer Lett
2 Cancer Res
1 Clin Cancer Res
1 J Clin Oncol
4 J Invest Dermatol
3 Melanoma Res
3 N Engl J Med
2 Oncogene
2 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. FALKENIUS J, Johansson H, Tuominen R, Frostvik Stolt M, et al
    Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma.
    BMC Cancer. 2017;17:584.
    PubMed     Text format     Abstract available


    Cancer Lett

  2. HOU X, Zhou H, Wang L, Tang J, et al
    Multifunctional near-infrared dye-magnetic nanoparticles for bioimaging and cancer therapy.
    Cancer Lett. 2017;390:168-175.
    PubMed     Text format     Abstract available


    Cancer Res

  3. YANG F, Wei J, Zhang S, Zhang X, et al
    Shrimp miR-S8 suppresses the stemness of human melanoma stem-like cells by targeting the transcription factor YB-1.
    Cancer Res. 2017 Aug 30. pii: canres.1375.2017.
    PubMed     Text format     Abstract available

  4. MAHNE AE, Mauze S, Joyce-Shaikh B, Xia J, et al
    Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy.
    Cancer Res. 2017;77:1108-1118.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. ENNEN M, Keime C, Gambi G, Kieny A, et al
    MITF-high and MITF-low cells and a novel subpopulation expressing genes of both cell states contribute to intra and inter-tumoral heterogeneity of primary melanoma.
    Clin Cancer Res. 2017 Aug 28. pii: clincanres.0010.2017.
    PubMed     Text format     Abstract available


    J Clin Oncol

  6. BURRIS HA, Infante JR, Ansell SM, Nemunaitis JJ, et al
    Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors.
    J Clin Oncol. 2017;35:2028-2036.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  7. VON SCHUCKMANN LA, Smith D, Hughes MCB, Malt M, et al
    Associations of statins and diabetes with diagnosis of ulcerated cutaneous melanoma.
    J Invest Dermatol. 2017 Aug 22. pii: S0022-202X(17)32797.
    PubMed     Text format     Abstract available

  8. THOMAS NE, Edmiston SN, Kanetsky PA, Busam KJ, et al
    Associations of MC1R genotype and patient phenotypes with BRAF and NRAS mutations in melanoma.
    J Invest Dermatol. 2017 Aug 22. pii: S0022-202X(17)32791.
    PubMed     Text format     Abstract available

  9. DELYON J, Chevret S, Jouary T, Dalac S, et al
    STAT3 mediates Nilotinib response in KIT-altered Melanoma: a Phase II Multicenter Trial of the French Skin Cancer Network.
    J Invest Dermatol. 2017 Aug 23. pii: S0022-202X(17)32802.
    PubMed     Text format     Abstract available

  10. DONOVAN P, Dubey OA, Kallioinen S, Rogers KW, et al
    Paracrine Activin-A signaling promotes melanoma growth and metastasis through immune evasion.
    J Invest Dermatol. 2017 Aug 24. pii: S0022-202X(17)32820.
    PubMed     Text format     Abstract available


    Melanoma Res

  11. ABOUDARAM A, Modesto A, Chaltiel L, Gomez-Roca C, et al
    Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination.
    Melanoma Res. 2017;27:485-491.
    PubMed     Text format     Abstract available

  12. LI Y, Umbach DM, Li L
    Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.
    Melanoma Res. 2017 Aug 28. doi: 10.1097/CMR.0000000000000388.
    PubMed     Text format     Abstract available

  13. TSIOGKA A, Jansky GL, Bauer JW, Koelblinger P, et al
    Fulminant type 1 diabetes after adjuvant ipilimumab therapy in cutaneous melanoma.
    Melanoma Res. 2017;27:524-525.
    PubMed     Text format    


    N Engl J Med

  14. BILIMORIA KY, Russell MC, Hyngstrom J
    Melanoma Sentinel-Node Metastasis.
    N Engl J Med. 2017;377:891.
    PubMed     Text format    

  15. FARIES MB, Cochran AJ, Thompson JF
    Melanoma Sentinel-Node Metastasis.
    N Engl J Med. 2017;377:892.
    PubMed     Text format    


  16. Melanoma Sentinel-Node Metastasis.
    N Engl J Med. 2017;377:891-2.
    PubMed     Text format    


    Oncogene

  17. SONG X, Hao J, Wang J, Guo C, et al
    The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling.
    Oncogene. 2017;36:1476-1486.
    PubMed     Text format     Abstract available

  18. BIANCHI-SMIRAGLIA A, Bagati A, Fink EE, Moparthy S, et al
    Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP pools.
    Oncogene. 2017;36:84-96.
    PubMed     Text format     Abstract available


    Oncol Rep

  19. WANG DM, Jiao X, Plotnikoff NP, Griffin N, et al
    Killing effect of methionine enkephalin on melanoma in vivo and in vitro.
    Oncol Rep. 2017 Aug 24. doi: 10.3892/or.2017.5918.
    PubMed     Text format     Abstract available

  20. MONTI P, Ghiorzo P, Menichini P, Foggetti G, et al
    TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear.
    Oncol Rep. 2017 Aug 14. doi: 10.3892/or.2017.5903.
    PubMed     Text format     Abstract available


    PLoS One

  21. ZHAO X, Kong F, Wang L, Zhang H, et al
    c-FLIP and the NOXA/Mcl-1 axis participate in the synergistic effect of pemetrexed plus cisplatin in human choroidal melanoma cells.
    PLoS One. 2017;12:e0184135.
    PubMed     Text format     Abstract available

  22. TARMANN L, Wackernagel W, Ivastinovic D, Schneider M, et al
    Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
    PLoS One. 2017;12:e0183833.
    PubMed     Text format     Abstract available

  23. KIM HS, Shin MS, Cheon MS, Kim JW, et al
    GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas.
    PLoS One. 2017;12:e0174565.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: